ZimVie (NASDAQ:ZIMV) Announces Quarterly Earnings Results

ZimVie (NASDAQ:ZIMV) issued its earnings results on Wednesday. The company reported $0.08 EPS for the quarter, Zacks reports. ZimVie had a negative net margin of 51.33% and a positive return on equity of 2.44%. The company had revenue of $118.20 million for the quarter. During the same quarter in the previous year, the firm posted $0.25 earnings per share. ZimVie updated its FY 2024 guidance to 0.550-0.700 EPS.

ZimVie Stock Up 10.3 %

Shares of NASDAQ:ZIMV traded up $1.59 during mid-day trading on Thursday, hitting $16.97. 935,702 shares of the company traded hands, compared to its average volume of 342,208. ZimVie has a 52-week low of $6.52 and a 52-week high of $20.91. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.32 and a current ratio of 2.78. The firm’s 50 day simple moving average is $16.40 and its 200 day simple moving average is $15.00. The firm has a market cap of $461.92 million, a P/E ratio of -1.04 and a beta of 2.17.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Barclays boosted their price target on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research note on Tuesday, March 5th. Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research note on Thursday.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.